![]() |
HEMATOPOIETIC
REGULATORY PATHWAYS
|
![]() |
|
|
What Controls Differentiation of Hematopoietic
Stem Cells?
Because of the required balance between self-renewal and differentiation, mechanisms that govern stem cell fate decisions must be under tight yet flexible control. Hematopoietic stem cell differentiation is controlled by the combined interactions of signal molecules and positive and negative transcription factors. However little is concretely known about the molecular nature of these mechanisms. |
|||
|
INTRINSIC
CONTROLS
|
|||
|
Intrinisc stem cell regulation involves:
These include transcription factors and cell cycle proteins that promote or inhibit changes in the cell cycle. SCL/Tal-1 is an example of a known transcription factor that is essential to blood cell formation, especially T lymphocytes. Cyclin-dependent kinase inhibitor p21cip1/waf1 is an example of a clock protein and plays a critical role in inhibiting differentiation and preventing stem cell exhaustion. Hox genes also play an important role in the regulation of proliferation. Evidence suggests involvement of Hox genes in the pathogenesis of human leukemias. (70) |
|||
|
EXTERNAL
CONTROLS
|
|||
|
Secreted factors from other cell types support survival of distinct progenitor populations. Integrins and extracellular matrices also affect cell fate. Integrins hold cells in the right place from tissue. In absence of integrin expression, the stem cell departs from its niche through differentiation or apoptosis. Integrins are also signaling receptors and can directly activate growth factor receptors. Extracellular matrix (ECM) proteins help modulate expression and activation of integrins and concentration of secreted factors in the niche. (70) |
|||
|
GENE
EXPRESSION OF HSC CELLS
|
|||
|
(72)
Alignments of important motifs (right) and subcellular localization (above) for five proteins identified in hematopoietic stem cells |
|||
|
WHY
IS IT IMPORTANT TO UNDERSTAND SIGNALING FACTORS |
|||
|
In Vitro differentiation of ES cells provides an opportunity to better
understand human hematopoiesis and could lead to a source of cells for
transfusion and transplantation therapies. In vitro hematopoietic differentiation
has therapeutic implications, such as the derivation of erythrocytes and
platelets for transfusions and hematopoietic stem cell transplantation.
Blood products could potentially be created in virtually unlimited amounts.
They could even be genetically engineered to combat specific diseases
or treatment of hematologic malignancies. In order to access the medical
possibilities of these stem cells we must first we must understand
the controls that cause them to differentiate. (65) |
|||